Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -0.61 |
peg ratio | 0.00 |
price to book ratio | 0.29 |
price to sales ratio | 0.78 |
enterprise value multiple | -1.44 |
price fair value | 0.29 |
profitability ratios | |
---|---|
gross profit margin | 97.75% |
operating profit margin | -139.9% |
pretax profit margin | -122.88% |
net profit margin | -126.34% |
return on assets | -40.72% |
return on equity | -40.87% |
return on capital employed | -53.09% |
liquidity ratio | |
---|---|
current ratio | 6.45 |
quick ratio | 6.55 |
cash ratio | 2.59 |
efficiency ratio | |
---|---|
days of inventory outstanding | -794.21 |
operating cycle | -776.36 |
days of payables outstanding | 2,601.39 |
cash conversion cycle | -3,377.75 |
receivables turnover | 20.45 |
payables turnover | 0.14 |
inventory turnover | -0.46 |
debt and solvency ratios | |
---|---|
debt ratio | 0.01 |
debt equity ratio | 0.01 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.01 |
interest coverage | -24.88 |
cash flow to debt ratio | -30.15 |
cash flow ratios | |
---|---|
free cash flow per share | -1.83 |
cash per share | 4.23 |
operating cash flow per share | -1.82 |
free cash flow operating cash flow ratio | 1.01 |
cash flow coverage ratios | -30.15 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -194.16 |
Frequently Asked Questions
Repare Therapeutics Inc. (RPTX) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Repare Therapeutics Inc. (NASDAQ:RPTX)'s trailing twelve months ROE is -40.87%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Repare Therapeutics Inc. (RPTX) currently has a ROA of -40.72%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
RPTX reported a profit margin of -126.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.45 in the most recent quarter. The quick ratio stood at 6.55, with a Debt/Eq ratio of 0.01.